Robert Andrade, CHIEF FINANCIAL OFFICER at FENNEC PHARMACEUTICALS INC. (FENC), sold 25,000 shares at $8.99 ($223K) on 2023-06-28, disclosed to the SEC on 2023-06-30.
Scheduled sale ($223k) by CHIEF FINANCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.99 | 10,000 | $90K | 40.3% |
| 2 | $8.97 | 7,500 | $67K | 30.1% |
| 3 | $8.82 | 7,500 | $66K | 29.6% |
| Total | $8.93 avg | 25,000 | $223K | 100% |
| Filing → |
| FENC | SELL | 2024-03-25 | $154K | — | Filing → |
| FENC | SELL | 2024-01-05 | $316K | — | Filing → |
| FENC | SELL | 2022-12-30 | $211K | — | Filing → |